Article
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Cancer research - 15 Mar 1997
Feigelson H S, Coetzee G A, Kolonel L N, Ross R K, Henderson B E
Abstract excerpt
We conducted a case-control study to determine whether a polymorphism in the CYP17 gene was associated with risk of breast cancer. We found an increased risk of advanced breast cancer in women carrying an A2 allele. The odds ratio was 2.5 [95% confidence interval (CI), 1.07-5.94] for regional or metastatic disease. Among controls, the A1/A1 genotype was associated with a later age at menarche. The reduced risk of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
